LYTIR

Company · PHIO

Phio Pharmaceuticals Corp.

Nasdaq's symbol directory lists PHIO on Nasdaq as “Phio Pharmaceuticals Corp. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 8 occasions ($69K); 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $69K in total; Insider sales: $0 in total.Jun: Insider purchases $10KAug: Insider purchases $28KSep: Insider purchases $31KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $69KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Plott Ronald Todd bought on 3 days latest Sep 29, 2026 bought $27K
  2. Bitterman Robert J, Chairman, Pres. & CEO bought on 3 days latest Sep 22, 2026 bought $23K
  3. BRADFORD PATRICIA A bought on 2 days latest Sep 24, 2026 bought $19K
Every trade (8)
  1. BUYPlott Ronald Todd bought Sep 29, 2026 5,000 shares filing $5K
  2. BUYPlott Ronald Todd bought Sep 28, 2026 5,000 shares filing $5K
  3. BUYBRADFORD PATRICIA A bought Sep 24, 2026 6,500 shares filing $7K
  4. BUYBitterman Robert J, Chairman, Pres. & CEO bought Sep 22, 2026 2,000 shares filing $2K
  5. BUYBRADFORD PATRICIA A bought Sep 15, 2026 12,000 shares filing $12K
  6. BUYPlott Ronald Todd bought Aug 19, 2026 15,000 shares filing $17K
  7. BUYBitterman Robert J, Chairman, Pres. & CEO bought Aug 18, 2026 10,000 shares filing $11K
  8. BUYBitterman Robert J, Chairman, Pres. & CEO bought Jun 26, 2026 10,000 shares filing $10K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Other events filing Oct 13, 2026
  3. Departure or appointment of directors or officers; Submission of matters to a vote of security holders filing Sep 28, 2026
  4. Other events filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.